Search

everythinglearnresearchcommunity

for

Search:↓

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Iodine-deficient diets and antithyroid substances affected rat growth and behavior, but most adapted with positive weight gain.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Men with testicular cancer were less likely to experience baldness and severe acne.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Bald men may have a lower risk of testicular cancer.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Baldness may lower the risk of testicular cancer.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Father's finasteride use may affect son's fertility and testicular function.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

A dog's hair loss was caused by a hormone-secreting testicular tumor.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.